Prof. Dr. Dirk Bohmann
Professor of Genetics, Center for Cancer Biology AAB Institute of Biomedical Sciences, University of Rochester, School of Medicine and Dentistry.

After studying biology, Prof. Bohmann received his doctorate in 1986 at the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg. Between 1986 and 1989 he worked in Prof. Robert Tjian's group at the Department of Biochemistry of the University of California at Berkeley. From 1989, Prof. Bohmann was a team leader at the European Molecular Biology Laboratory and in 1996 was promoted to Senior Scientist at this institute. In 1997 he qualified as a university lecturer in the field of molecular biology at the faculty of biology of the University of Heidelberg and was recently appointed by the University of Rochester.

Prof. Dr. Wieland Huttner
Manager of the Neurobiology Department at the Interdisciplinary Center for Neurosciences (IZN) at the University of Heidelberg and director at the Max Planck Institute for Molecular Cellular Biology and Genetics in Dresden.

Between 1976 and 1980, Prof. Huttner initially worked as a post-doctoral fellow at the Max Planck Institute for Experimental Medicine, then as a post-doctoral fellow and research associate in Prof. Paul Greengard’s team at Yale University School of Medicine, New Haven (CT), in the Department of Pharmacology. Between 1981 and 1985, Prof. Huttner was employed as a junior team leader in the Neurochemistry Department at the Max Planck Institute for Psychiatry in Martinsried/Munich. Between 1985 and 1990 he was a team leader at the European Molecular Biology Laboratory in Heidelberg, from where he was appointed in 1991 as the head of the Institute for Neurobiology at the University of Heidelberg. Prof. Huttner is one of managing directors of the newly formed Max Planck Institute for Molecular Cellular Biology and Genetics in Dresden.

Prof. Dr. Hans-Jürgen Quadbeck-Seeger
Former member of the executive board of BASF AG.

Prof. Quadbeck-Seeger studied chemistry at Munich University where he also received his doctorate. In 1985 he was appointed as chairman of the executive board of KNOLL AG and became responsible for the management of the pharmaceutical division of BASF AG. Between 1990 and 1997, Prof. Quadbeck-Seeger was a member of the executive board of BASF AG, in charge of corporate research. Since 1996, he has been a member of the senate of the Max Planck Society.

Prof. Dr. Gert Riethmüller
Executive board of the Institute for Immunology of Ludwig Maximilian University, Munich

After studying medicine and following a post-doctoral period at well-known universities in Europe and America, Prof. Riethmüller qualified in 1971 as a university lecturer at Tübingen University, where he became head of the Immunology and Experimental Surgery Department. In 1977 he became professor for Immunology of Ludwig Maximilian University in Munich, of which he is the director to date. Since 1979 he has also been the head of the Tumor Center of Munich at the Institute of University. The list of his awards is long; the most important of these include the Gerhard-Domagk prize for Cancer Research, the Meyenburg prize of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg and the honorary doctorate of the medical faculty of Greifswald University and of Hannover Medical College. Prof. Riethmüller is a member of the advisory boards of numerous domestic and foreign research centers, foundations and institutes. He is highly recognized internationally for the development of monoclonal antibodies and their everyday clinical use, for example, in rheumatoid arthritis and other auto-immune diseases. He has made a decisive contribution to immune therapy and especially to the antibody therapy of cancer diseases.

Prof. Dr. Dr. h.c. Thomas Schreckenbach
Former general partner and member of the executive board of Merck KGaA.

Prof. Schreckenbach studied chemistry at Munich University and received his doctorate there. Between 1979 and 1986 he was the head of a working group of the "Membrane Chemistry" Department at the Max Planck Institute for Biochemistry in Martinsried. In 1986, Prof. Schreckenbach joined E. Merck, Darmstadt, as head of biochemical research. There he was manager of central chemical research between 1987 and 1988, manager of the pigments division between 1989 and 1990 and in 1991 was appointed to the executive management. He was responsible for the division of specialty chemicals, research chemistry, central research services, analysis and scientific information.

Prof. Dr. Dr. h.c. Günter Stock
Former member of the executive board of Schering AG.

Prof. Stock studied medicine at Heidelberg University, qualified as a university lecturer in 1978 for the Faculty of Physiology and received a professorship for the Vegetative Physiology Faculty in 1980. In 1983 he joined Schering AG as manager of the main department of Heart/Cardiovascular Pharmacology and assumed management of the Institute for Pharmacology of Schering in 1987. In 1989 he was appointed to the executive board of Schering AG and was in charge of the corporate research and development function and supervising the strategic business units for the Latin America region.